|
2016, Vol. 7(2): 201-214 DOI: 10.14336/AD.2015.1007 | ||
Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies | ||
Isaac G. Onyango1,*, Jameel Dennis1, Shaharyah M. Khan1 | ||
1. Gencia Biotechnology, 706 B Forest St, Charlottesville, VA 22903, USA | ||
Received 2015-09-02 Revised null | ||
Supporting info | ||